DEA Archived Press Releases

Press Releases before January 20, 2025
37 Results - Showing 1 to 10
PRESS RELEASE

U.S. Attorney’s Office and DEA Announce Fatal Fentanyl Overdose Task Force

Baltimore, Maryland – Erek L. Barron, U.S. Attorney for the District of Maryland and Jarod Forget, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) Washington Division, announced that their agencies have formed the Maryland Fatal Fentanyl Overdose Task Force (“MFFOTF”). The alarming rate of overdoses in Maryland has...
PRESS RELEASE

DEA Washington Division Calls on the Community to Have Important Conversations on Dangers of Drugs and Fake Pills in Back-To-School Routines

Washington, DC – As schools in the District of Columbia, Maryland, and Virginia open their doors to students and teachers this month, the Drug Enforcement Administration (DEA) Washington Division is urging the community to have important conversations about the consequences of drug experimentation and misuse as the new school year...
PRESS RELEASE

Powerful Stories and Connections During DEA Washington Division’s 3rd Family Summit on Fentanyl

WASHINGTON, DC – On June 18, the Drug Enforcement Administration (DEA) Washington Division hosted their 3rd Family Summit in support of those who have lost loved ones to fentanyl poisoning in the District of Columbia, Maryland, and Virginia (DMV). In alignment with DEA's mission, the event aimed to provide opportunities...
PRESS RELEASE

DEA Washington Division Saw a Surge of Over 250% in Fentanyl Pill Seizures in 2023

Washington, DC – The Drug Enforcement Administration’s (DEA) Washington Division, which covers the District of Columbia, Maryland, and Virginia (DMV) confiscated more than 639,000 fentanyl pills and 189 pounds of fentanyl powder in 2023. This amount represents more than a three-fold increase in the number of fake pills laced with...
PRESS RELEASE

DEA’s National Prescription Drug Take Day Removes Almost 600,000 Pounds of Unneeded Prescription Medications Across the Country

WASHINGTON, DC – On October 28, 2023, the community once again emptied their medicine cabinets to help dispose of old, unwanted, and expired medications. Nationwide, DEA and its law enforcement partners collected 599,897 pounds of unneeded medications at 4,675 collection sites nationwide. Locally, the Washington Division, which includes the District...
PRESS RELEASE

DEA Washington Division is Ready to Celebrate the 25th National Drug Take Back Day Across the DMV

Washington, DC – The Drug Enforcement Administration (DEA) will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. in more than 300 collection sites across Maryland, District of Columbia, and Virginia (DMV). Through a collaborative effort with local law enforcement...
PRESS RELEASE

DEA Washington Division Holds Second Annual Family Summit on Fentanyl

WASHINGTON, DC – On October 6, the Drug Enforcement Administration (DEA) Washington Division hosted their 2nd Family Summit in support of those who have lost loved ones to fentanyl poisoning in the District of Columbia, Maryland, and Virginia. The Summit was very emotional and educational to all those who attended...
PRESS RELEASE

Former Chief Operating Officer of Area Pain Clinics Indicted

CHARLOTTESVLLE, Va. – A federal grand jury returned an indictment this week charging the former chief operating officer of area pain clinics with three conspiracy counts for her alleged involvement in health care fraud and illegal drug distribution. Jennifer Ann “Jen” Adams, 50, of Mount Pleasant, South Carolina, is charged...
PRESS RELEASE

DEA Washington Division Encourages Back to School Drug Awareness and Education

WASHINGTON, D.C. – As students return to school across the DMV, the DEA's Washington Division urges families to have open conversations about the dangers of drug experimentation and use. “Our citizens, especially our youth, are being exposed to an illicit drug supply that is more dangerous than ever before, making...
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...